BIO INX, a leading innovator in materials for 3D bioprinting, is proud to announce the launch of BIORES INX, the latest addition to its cutting-edge portfolio of bioprinting resins. Building on decades of expertise in gelatin-based formulations, BIORES INX represents a significant breakthrough in bioprinting technology, offering unparalleled ease of use, biocompatibility, and compatibility with DLP (digital light processing) bioprinting platforms.
Integration of digital twins, CAD, PLM and certification technologies paves the way for future advancements in personalized medical devices
From October 9 to 12, WASP will attend two international trade fairs, showcasing its 3D printing technologies for the construction and medical sectors
In recent years, metal additive manufacturing technology has gained significant support from governments and medical organizations, emerging as a pioneering force in the development of medical products. The combination of additive manufacturing with healthcare has gradually permeated every stage of medical processes, from preoperative planning to surgical implants and postoperative rehabilitation.
Medical facilities and device manufacturers previously limited by constraints can now create patient-specific models to enhance surgical preparation, elevate patient outcomes, and fast-track innovation
XJet has today announced the addition of 17-4PH stainless steel to its portfolio of materials for metal and ceramic additive manufacturing. The new material, offering high hardness and tensile strength, has been introduced to expand industrial applications across a range of sectors including medical devices and surgical instruments, aerospace and defense, oil and gas filtration, and high-precision tooling and manufacturing.
At Exposanità 2024, WASP demonstrates the potential of 3D printing in the medical sector bringing six case studies realized with WASP’s technologies
• Open system: Freeformer 750-3X processes plastic pellets reliably and cost-efficiently
Recently, the Hydroxyapatite-Coated Porous Titanium Alloy Interbody Fusion Device (WedoCageTM) developed by Wedo Bio-Medical Technology Co, Ltd. (hereinafter referred to as " Wedo"), has officially received market approval after obtaining the Class III Medical Device Registration Certificate from the National Medical Products Administration (NMPA).
Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer 3D printing and additive manufacturing solutions, today announced it has partnered with Siemens Healthineers to carry out a landmark research project designed to develop new state-of-the-art solutions for the advancement of medical imaging phantoms for computed tomography (CT) imaging.